Targeting IL-17 and TH17 cells in chronic inflammation
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
The key role of interleukin-17 (IL-17) and T helper 17 (T(H)17) cells in tissue inflammation, autoimmunity and host defence led to the experimental targeting of these molecules in mouse models of diseases as well as in clinical settings. Moreover, the demonstration that IL-17 and T(H)17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-T(H)17 cell pathway is regulated by IL-23, prompted the identification of inhibitors. These inhibitors include biotechnology products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A. Several clinical trials of these inhibitors are underway, and positive results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis. This Review focuses on the current knowledge of the IL-17-T(H)17 cell pathway to better understand the positive as well as potential negative consequences of targeting them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abs against IL-17/IL-17RA are in clinical trials for other autoimmune conditions [55].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [55]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Research works printed but not linked: 1
- Baeten, D. et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 62, Abstract L3847 (2010).
Cited by
Items 301–400 of 1,000
Khan, M. Z., Wang, J., Ma, Y., Chen, T., Ma, M., Ullah, Q., Khan, I. M., Khan, A. A., Cao, Z., & Liu, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1082144 · Cited by 75
Research progress of targeted therapy regulating Th17/Treg balance in bone immune diseases
Wang, X., Sun, B. T., Wang, Y., Gao, P., Song, J., Chang, W., Xiao, Z., Xi, Y., Li, Z., An, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1333993 · Cited by 72
“Th17 cells have been shown to promote the production of matrix metalloproteinases and the in fl ux of immune cells by secreting in fl ammatory cytokines, such as IL-17, IL-21, TNF-a , and IL-6, and aggravate joint destruction while maintaining in fl ammatory reaction (34, 80, 81).”
BackgroundGaspari, A. A., & Tyring, S. K. (2015) · Dermatologic Therapy · doi:10.1111/dth.12251 · Cited by 72
“RG7624, an antibody that targets both IL-17A and IL-17F, is also being investigated for the treatment of psoriasis but no clinical trial results have been reported for this agent (45).”
BackgroundRodgers, D. T., McGrath, M. A., Pineda, M. A., Al‐Riyami, L., Rzepecka, J., Lumb, F., Harnett, W., & Harnett, M. M. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39004 · Cited by 55
“Studies in interleukin-23 (IL-23)– deficient mice suggest that the IL-23/IL-17 axis promotes such kidney inflammation (4), and, perhaps reflecting this, expanded populations of Th17- and IL-17– producing CD3 CD4 CD8 T cells are observed in the kidneys of both lupus-prone mice and patients with SLE (5).”
BackgroundRetinoid-related orphan receptor γ (RORγ) adult induced knockout mice develop lymphoblastic lymphoma
Liljevald, M., Rehnberg, M., Söderberg, M. P., Ramnegård, M., Börjesson, J., Luciani, D., Krutrök, N., Brändén, L., Johansson, C., Xu, X., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.036 · Cited by 60
Hsu, D., Taylor, P. R., Fletcher, D., Heeckeren, R. V., Eastman, J. F., van Heeckeren, A. M., Davis, P. B., Chmiel, J. F., Pearlman, E. M., & Bonfield, T. L. (2016) · Infection and Immunity · doi:10.1128/iai.00284-16 · Cited by 60
“In clinical studies analyzing sputum samples induced at the beginning and end of 2 weeks of intravenous antibiotic therapy in patients with CF experiencing a pulmonary exacerbation, the clinical outcome demonstrated only a modest reduction in neutrophils and IL-8, despite a 2- to 3-log reduction in the bacterial count…”
BackgroundInterleukin 17A in atherosclerosis – Regulation and pathophysiologic effector function
Nordlohne, J., & von Vietinghoff, S. (2017) · Cytokine · doi:10.1016/j.cyto.2017.06.016 · Cited by 61
“muscle cells, pericytes, macrophages, and T cells [5,11,12].”
BackgroundBai, A., & Guo, Y. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.360 · Cited by 56
Huo, W., Liu, Y., Lei, Y., Zhang, Y., Huang, Y., Mao, Y., Wang, C., Sun, Y., Zhang, W., Ma, Z., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.01.024 · Cited by 59
Mesenchymal Stem Cells and Atopic Dermatitis: A Review
Daltro, S. R. T., Meira, C. S., Santos, I. P., dos Santos, R. R., & Soares, M. B. P. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00326 · Cited by 58
“Interleukin-17 stimulates the production of IL-6 and IL-8 by human keratinocytes, which lead to increased T cell migration to the skin (Nutten, 2015; Miossec and Kolls, 2012; Sidburry and Khorsand, 2017; Campione et al., 2020).”
BackgroundGlutamine metabolism in Th17/Treg cell fate: applications in Th17 cell-associated diseases
Yang, G., Xia, Y., & Ren, W. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1703-2 · Cited by 57
Ferreira, L. S., Gonçalves, A. C., Portuondo, D. L., Maia, D. C. G., Placeres, M. C. P., Batista-Duharte, A., & Carlos, I. Z. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.02.009 · Cited by 62
Shen, Z., Gao, X., Ma, L., Zhou, Z., Shen, X., & Liu, W. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1429-3 · Cited by 55
Focal bone involvement in inflammatory arthritis: the role of IL17
Rossini, M., Viapiana, O., Adami, S., Idolazzi, L., Fracassi, E., & Gatti, D. (2015) · Rheumatology International · doi:10.1007/s00296-015-3387-x · Cited by 59
Recent developments on dry eye disease treatment compounds
Colligris, B., Alkozi, H. A., & Pintor, J. J. (2013) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2013.12.003 · Cited by 67
“In the same direction Schepens Eye Research Institute (patent WO/2009/089036)(42) is developing a composition which is inhibiting the function of the inflammatory cytokine IL-17 that acts as a potent mediator to inflammatory processes.(43,44) The composition was designed”
BackgroundT-cell phenotypes in chronic rhinosinusitis with nasal polyps in Japanese patients
Baba, S., Kagoya, R., Kondo, K., Suzukawa, M., Ohta, K., & Yamasoba, T. (2015) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-015-0100-2 · Cited by 57
“IL-17A has been revealed to play a significant role in regulating inflammation, modulating airway structural cells and stimulating innate immunity to mediate neutrophil recruitment in asthma and other airway diseases [16].”
BackgroundHuynh, J., Scholz, G. M., Aw, J., Kwa, M. Q., Achuthan, A. A., Hamilton, J. A., & Reynolds, E. C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501263 · Cited by 57
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity
Kurdi, A. T., Bassil, R., Olah, M., Wu, C., Xiao, S., Taga, M. F., Frangieh, M., Buttrick, T., Orent, W., Bradshaw, E. M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13048 · Cited by 57
Vitamin E isoform γ-tocotrienol protects against emphysema in cigarette smoke-induced COPD
Peh, H. Y., Tan, W. S. D., Chan, T. K., Pow, C. W., Foster, P. S., & Wong, W. S. F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.06.023 · Cited by 60
Michaudel, C., Bataille, F., Maillet, I., Fauconnier, L., Colas, C., Sokol, H., Straube, M., Couturier-Maillard, A., Dumoutier, L., Snick, J. V., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00144 · Cited by 55
“, IL-6 and IL-8), chemokines, and molecules involved in tissue remodeling, such as MMPs (27).”
BackgroundInterleukin-17A (IL-17A): A silent amplifier of COVID-19
Μaione, F., Casillo, G. M., Raucci, F., Salvatore, C., Ambrosini, G., Costa, L., Scarpa, R., Caso, F., & Bucci, M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111980 · Cited by 67
“In particular, it is becoming apparent that in some patients, severe COVID-19 disease is accompanied by a fulminant immune reaction characterized by pronounced infiltration of macrophages and monocytes into the alveolae, a pro-inflammatory Thelper 17 (Th17) response, and elevated levels of inflammatory cytochemokines…”
InfluentialPeng, G., & Fadeel, B. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114422 · Cited by 56
Shibabaw, T., Teferi, B., & Ayelign, B. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1094823 · Cited by 57
Elevated plasma interleukin-17A in a subgroup of Myasthenia Gravis patients
Xie, Y., Li, H., Jiang, B., Li, Y., Kaminski, H. J., & Kusner, L. L. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.011 · Cited by 60
Noack, M., Ndongo-Thiam, N., & Miossec, P. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-1046-6 · Cited by 59
“Interleukin-17 (IL-17) is a pro-inflammatory cytokine mainly produced by Th17 cells and involved in several chronic inflammatory diseases, such as psoriasis or rheumatoid arthritis (RA) [1, 2].”
BackgroundSelf-citationIL-17 Promotes Scar Formation by Inducing Macrophage Infiltration
Zhang, J., Qiao, Q., Liu, M., He, T., Shi, J., Bai, X., Zhang, Y., Li, Y., Cai, W., Han, S., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.04.005 · Cited by 62
Interleukin-17 as a potential therapeutic target for chronic pain
Jiang, X., Zhou, R., Zhang, Y., Zhu, T., Li, Q., & Zhang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.999407 · Cited by 61
“The IL-17 family consists of six other family molecules (IL17B, IL-17C, IL-17D, IL-17E (IL-25), and IL-17F) with structural identity (11).”
BackgroundPetrasca, A., Hambly, R., Kearney, N., Smith, C. M., Pender, E., Mahon, J. M., O’Rourke, A. M., Ismaiel, M., Boland, P. A., Almeida, J. P., et al. (2023) · British Journal of Dermatology · doi:10.1093/bjd/ljad305 · Cited by 57
“…in HS pathogenesis, 38,39 and is linked to the production of various cytokines, including IL-17 40,41 – a key player in inflammatory diseases, including HS. 42,43 As mentioned above, in Figure 6 Metformin (Met) inhibits inflammasome activation and mammalian target of rapamycin (mTOR) in vitro .”
γδ T Cells as a Major Source of IL-17 Production During Age-Dependent RPE Degeneration
Zhao, Z., Xu, P., Jie, Z., Zuo, Y., Yu, B., Soong, L., Sun, J., Chen, Y., & Cai, J. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15166 · Cited by 55
Emerging strategies for cancer immunoprevention
Roeser, J. C., Leach, S. D., & McAllister, F. (2015) · Oncogene · doi:10.1038/onc.2015.98 · Cited by 52
“T H 17 and Interleukin-17: IL-17A, a pro-inflammatory cytokine produced mainly by CD4+T cells known as T H 17 (T Helper 17) cells, plays a key role in chronic inflammation-related human diseases and autoimmunity [56, 57].”
BackgroundAdult atopic dermatitis and the risk of type 2 diabetes
Andersen, Y. M. F., Egeberg, A., Gislason, G., Skov, L., Knop, F. K., & Thyssen, J. P. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.049 · Cited by 53
Kan, X., Zhang, W., You, R., Niu, Y., Guo, J., & Xue, J. (2017) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1551-9 · Cited by 52
“T helper 17 (Th17) cells are an important inflammatory component and have been shown to promote inflammation in a number of autoimmune diseases [35].”
BackgroundIL ‐17 in neonatal health and disease
Lawrence, S. M., Ruoss, J. L., & Wynn, J. L. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12800 · Cited by 60
Maruthamuthu, V., Henry, L. J. K., Ramar, M., & Kandasamy, R. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112369 · Cited by 56
Th17/IL-17 Axis Regulated by Airway Microbes Get Involved in the Development of Asthma
Liu, D., Tan, Y., Bajinka, O., Wang, L., & Tang, Z. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00903-x · Cited by 57
Najafi, S., Rajaei, E., Moallemian, R., & Nokhostin, F. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05376-x · Cited by 58
Genetic Associations and Architecture of Asthma-COPD Overlap
John, C., Guyatt, A. L., Shrine, N. R. G., Packer, R. J., Olafsdottir, T. A., Liu, J., Hayden, L. P., Chu, S. H., Koskela, J. T., Luan, J., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2021.12.674 · Cited by 59
Gołąbek-Grenda, A., & Olejnik, A. M. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110375 · Cited by 59
Li, J., Zhao, J., Chen, L., Gao, H., Zhang, J., Wang, D., Zou, Y., Qin, Q., Qu, Y., Li, J., et al. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.023 · Cited by 56
Criscitiello, C., Viale, G., Gelao, L., Espósito, A., Laurentiis, M. D., Placido, S. D., Santangelo, M. L., Goldhirsch, A., & Curigliano, G. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.12.001 · Cited by 59
“Indeed recent evidence from clinical trials suggests potential therapeutic implications for IL17/Th17 inhibition in a large spectrum of chronic inflammatory diseases [25].”
BackgroundImmunological basis in the pathogenesis of intrahepatic cholestasis of pregnancy
Larson, S. P., Kovilam, O. P., & Agrawal, D. K. (2015) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2016.1101344 · Cited by 56
“The final cytokine increased is IL-17A, which was originally identified as CTL-associated antigen 8, and the increase is only significant in patients with severe ICP or who had total bile acid concentrations greater than or equal to 40 μmol/L.[45] IL-17 can induce production of IL-6 and IL-8, a chemokine ligand that r…”
BackgroundInfluentialHaruta, K., Otaki, N., Nagamine, M., Kayo, T., Sasaki, A., Hiramoto, S., Takahashi, M., Hota, K., Sato, H., & Yamazaki, H. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0627 · Cited by 58
Tohme, S. T., Yazdani, H. O., Sud, V., Loughran, P., Huang, H., Zamora, R., Simmons, R. L., Vodovotz, Y., & Tsung, A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800454 · Cited by 56
“asthma, systemic lupus erythematosus, multiple sclerosis, and allograft rejection; however, little is known regarding the role of IL-17A in innate immunity or its role regarding acute liver I/R injury (24, 25).”
BackgroundRole of interleukin-17 in acute myocardial infarction
Mora-Ruíz, M. D., Blanco-Favela, F. A., Chávez-Rueda, A. K., Legorreta-Haquet, M. V., & Chávez-Sanchéz, L. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.008 · Cited by 57
Galluzzo, M., D’Adamio, S., Silvaggio, D., Lombardo, P., Bianchi, L., & Talamonti, M. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1708897 · Cited by 52
Maresin1 ameliorates acute lung injury induced by sepsis through regulating Th17/Treg balance
Xia, H., Wang, F., Wang, M., Wang, J., Sun, S., Chen, M., Huang, S., Chen, X., & Yao, S. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117773 · Cited by 56
Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms
Wang, Y., Fang, S., & Zhou, H. (2023) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2023.101743 · Cited by 59
Wang, J., Mei, L., Hao, Y., Xu, Y., Yang, Q., Dai, Z., Yang, Y., Wu, Z., & Ji, Y. S. (2024) · Nutrients · doi:10.3390/nu16142352 · Cited by 55
Anti-cytokine therapy in the treatment of psoriasis
Kupetsky, E. A., Mathers, A. R., & Ferris, L. K. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.027 · Cited by 57
Rho Kinases in Autoimmune Diseases
Pernis, A. B., Ricker, E., Weng, C.-H., Rozo, C., & Yi, W. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051914-022120 · Cited by 50
Role of cytokines and other factors involved in theMycobacterium tuberculosisinfection
Romero-Adrián, T. B. (2015) · World Journal of Immunology · doi:10.5411/wji.v5.i1.16 · Cited by 73
Azreq, M.-A. E., Kadiri, M., Boisvert, M., Pagé, N., Tessier, P. A., & Aoudjit, F. (2016) · Oncotarget · doi:10.18632/oncotarget.10455 · Cited by 51
“They play important roles in anti-microbial immunity [20], autoimmune diseases [21-23], and have been implicated in tumor growth and anti-cancer immunity [24].”
Biomimetic and Bioinspired Intervention Strategies for the Treatment of Rheumatoid Arthritis
Han, Y., Pang, X., & Pi, G. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104640 · Cited by 55
Osteoinmunología: el estudio de la relación entre el sistema inmune y el tejido óseo
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica · doi:10.1016/j.reuma.2013.02.008 · Cited by 60
Fang, Y., Chen, M., Li, G., Yang, Y., He, P., Chen, J., Cheng, L., & Wu, H. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215839 · Cited by 53
Maher, C. O., Dunne, K., Comerford, R., O’Dea, S., Loy, A., Woo, J., Rogers, T. R., Mulcahy, F. M., Dunne, P. J., & Doherty, D. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403066 · Cited by 58
“Therapeutic inhibition of the IL-23/IL-17 axis is currently under consideration for inflammatory and autoimmune diseases (36, 37).”
BackgroundOsteoimmunology: The Study of the Relationship Between the Immune System and Bone Tissue
Arboleya, L. R., & Castañeda, S. (2013) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2013.02.004 · Cited by 67
Regulation of Osteoclast Homeostasis and Inflammatory Bone Loss by MFG-E8
Abe, T., Shin, J., Hosur, K. B., Udey, M. C., Chavakis, T., & Hajishengallis, G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400970 · Cited by 53
“Although the antiinflammatory and anti-osteoclastogenic effects of MFG-E8 can be readily dissociated and investigated separately in vitro, the strong connection between inflammation and osteoclastogenesis (31) suggests that MFG-E8 is capable of a two-pronged attack on periodontitis and perhaps other inflammatory bone…”
BackgroundThe Interrelationship Between Diabetes, IL-17 and Bone Loss
Huang, Z., Pei, X., & Graves, D. T. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00559-6 · Cited by 56
Zhang, J., Li, Q., Zou, Y.-R., Wu, S., Lu, X., Li, G., & Wang, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107433 · Cited by 53
Zhong, L., Luo, N., Zhong, X., Xu, T., & Hao, P. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109032 · Cited by 52
Zhang, J., Zhou, R., Deng, L., Cao, G., Zhang, Y., Xu, H., Hou, J., Ju, S., & Yang, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112948 · Cited by 55
Alunno, A., Carubbi, F., Bartoloni, E., Bistoni, O., Caterbi, S., Cipriani, P., Giacomelli, R., & Gerli, R. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.08.022 · Cited by 51
“Given the pivotal role of IL-17 in the pathogenesis of autoimmune/inflammatory disorders, selective targeting of IL-17 axis for therapeutic purposes gained growing scientific interest in a variety of diseases [88].”
BackgroundInfluentialEmerging treatments for pemphigoid diseases
Ludwig, R. J., Kalies, K., Köhl, J., Zillikens, D., & Schmidt, E. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.003 · Cited by 49
Gege, C. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1153066 · Cited by 51
“In addition, TH17 cells or their products have been shown to be associated with the pathology of a variety of human inflammatory and autoimmune disorders including rheumatoid arthritis (RA), psoriasis, Crohn's disease, inflammatory bowel disease (IBD) and steroid-resistant asthma [3,4].”
Shear stress inhibits IL-17A-mediated induction of osteoclastogenesis via osteocyte pathways
Liao, C., Cheng, T., Wang, S., Zhang, C., Jin, L., & Yang, Y. (2017) · Bone · doi:10.1016/j.bone.2017.04.003 · Cited by 49
Visvanathan, S., Baum, P., Salas, A., Vinisko, R., Schmid, R., Grebe, K. M., Davis, J. W., Wallace, K. L., Böcher, W. O., Padula, S. J., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy099 · Cited by 51
Cimato, T. R., Palka, B., Lang, J. K., & Young, R. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073861 · Cited by 49
Ramani, K., Pawaria, S., Maers, K., Huppler, A. R., Gaffen, S. L., & Biswas, P. S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-184r · Cited by 48
Megna, M., Potestio, L., Camela, E., Fabbrocini, G., & Ruggiero, A. (2022) · Dermatologic Therapy · doi:10.1111/dth.15667 · Cited by 51
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches
Elahi, R., Nazari, M., Mohammadi, V., Esmaeilzadeh, K., & Esmaeilzadeh, A. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.009 · Cited by 53
IL-23/Th17 axis is not influenced by TNF-blocking agents in ankylosing spondylitis patients
Milanez, F. M., Saad, C. G. S., Viana, V. T., de Moraes, J. C. B., Périco, G. V., Sampaio-Barros, P. D., Gonçalves, C. R., & Bonfá, E. (2016) · Arthritis Research & Therapy · doi:10.1186/s13075-016-0949-6 · Cited by 48
“Of note, IL-23 can stimulate innate immune cells to produce other proinflammatory cytokines, including TNF, IL-22, and IL-17 family members [15, 43].”
BackgroundNosratabadi, R., Rastin, M., Sankian, M., Haghmorad, D., & Mahmoudi, M. (2016) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2016.04.001 · Cited by 48
“However, Th1/Th2 paradigm in EAE/MS has been challenged with identification of Th17 as well as Treg cells.(32) Hyperforin inhibited the differentiation and activation of Th17 and Th1 cells and induced Treg cell differentiation.”
BackgroundInterplay Between Inflammation and Epigenetic Changes in Cancer
Maiuri, A. R., & O’Hagan, H. M. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.09.002 · Cited by 55
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3
Zhang, C.-J., Wang, C., Jiang, M., Gu, C., Xiao, J., Chen, X., Martin, B. N., Tang, F., Yamamoto, E. A., Xian, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04974-3 · Cited by 55
The Role of Interleukin-17A in Psoriatic Disease
Adami, S., Cavani, A., Rossi, F., & Girolomoni, G. (2014) · BioDrugs · doi:10.1007/s40259-014-0098-x · Cited by 52
“Table 1 Pathophysiological actions of IL-17 [17, 70]”
BackgroundInfluentialKakeda, M., Schlapbach, C., Danelon, G., Tang, M. M., Cecchinato, V., Yawalkar, N., & Uguccioni, M. (2014) · Archives of Dermatological Research · doi:10.1007/s00403-014-1488-0 · Cited by 48
Wang, Z., Tan, J., Lei, L., Sun, W., Wu, Y., Ding, P., & Chen, L. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.02.002 · Cited by 47
Noack, M., Ndongo-Thiam, N., & Miossec, P. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12830 · Cited by 47
Self-citationMaekawa, T., Kulwattanaporn, P., Hosur, K. B., Domon, H., Oda, M., Terao, Y., Maeda, T., & Hajishengallis, G. (2017) · Journal of Dental Research · doi:10.1177/0022034516687248 · Cited by 52
Immunomodulatory Properties of Stem Cells in Periodontitis: Current Status and Future Prospective
Wang, M., Xie, J., Wang, C., Zhong, D., Xie, L., & Fang, H. (2020) · Stem Cells International · doi:10.1155/2020/9836518 · Cited by 56
“Meanwhile, chemokine receptor (CCR) 2 and CCR6 are secreted by Th17 cells [30, 31].”
BackgroundAbietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice
Li, X. Q., Chen, Y., Dai, G.-C., Zhou, B., Yan, X., & Tan, R. X. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113934 · Cited by 49
ApoB-Specific CD4+ T Cells in Mouse and Human Atherosclerosis
Marchini, T., Hansen, S., & Wolf, D. (2021) · Cells · doi:10.3390/cells10020446 · Cited by 53
“They are activated by IL‐23 and secrete the cytokines IL‐17A and ‐F [63].”
BackgroundYu, M., Meng, T., He, W., Huang, H. Y., Liu, C., Fu, X., He, J., Yin, Y., & Xiao, D. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c06029 · Cited by 47
Xue, Y., Zhou, Y., Bao, W., Fu, Q., Hao, H., Han, L., Zhang, X., Tian, X., & Zhang, M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.717962 · Cited by 50
“Although often classified as a Th2-related cytokine, IL-6 has an important role in a pathway of the initial differentiation of mouse Th17 cells (Miossec and Kolls, 2012).”
BackgroundCausal analysis between altered levels of interleukins and obstructive sleep apnea
Yi, M., Zhao, W., Fei, Q., Tan, Y., Liu, K., Chen, Z., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888644 · Cited by 48
“Under the regulation of IL-23, IL-17 can interact with other pro-inflammation interleukins like IL-1b and IL-6 and upregulate inflammation (39, 40).”
BackgroundGut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy
He, Y., Huang, J., Li, Q., Xia, W., Zhang, C., Liu, Z., Xiao, J., Yi, Z., Deng, H., Xiao, Z., et al. (2022) · Cancers · doi:10.3390/cancers14215317 · Cited by 50
“Targeting IL-17 and Th17 cells has yielded some results in the treatment of chronic inflammation [80].”
PET/MR imaging of inflammation in atherosclerosis
Senders, M. L., Calcagno, C., Tawakol, A. A., Nahrendorf, M., Mulder, W. J. M., & Fayad, Z. A. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00970-7 · Cited by 46
Interleukin-17 and lupus: enough to be a target? For which patients?
Robert, M., & Miossec, P. (2019) · Lupus · doi:10.1177/0961203319891243 · Cited by 48
Self-citationThe Th17 Pathway in Vascular Inflammation: Culprit or Consort?
Robert, M., Miossec, P., & Hot, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.888763 · Cited by 48
“From large to small vasculitis, histopathological lesions are different but evidence hints that T-helper (Th)-17 cells and IL-17A are involved in their pathogenesis (1).”
BackgroundInfluentialSelf-citationSummers, S. A., Odobasic, D., Khouri, M. B., Steinmetz, O. M., Yang, Y. H., Holdsworth, S. R., & Kitching, A. R. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12287 · Cited by 46
Promotion of lung tumor growth by interleukin-17
Xu, B., Guenther, J. F., Pociask, D. A., Wang, Y., Kolls, J. K., You, Z., Chandrasekar, B., Shan, B., Sullivan, D. E., & Morris, G. F. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00125.2014 · Cited by 48
“IL-17RA is expressed ubiquitously, whereas IL-17RC is mainly expressed in epithelial cells and fibroblasts (47).”
BackgroundSelf-citationLoss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation
Principe, D. R., DeCant, B., Staudacher, J., Vitello, D., Mangan, R. J., Wayne, E. A., Mascariñas, E., Diaz, A. M., Bauer, J., McKinney, R. D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.9830 · Cited by 43
“For example, TGFβ can convert CD4+ T helper cells to suppressive CD4+FoxP3+ regulatory T cells (Tregs), which in turn inhibit cell-mediated immunity via the release of suppressive factors such as IL10 [13].”
Alteber, Z., Sharbi‐Yunger, A., Pevsner‐Fischer, M., Blat, D., Roitman, L., Tzehoval, E., Elinav, E., & Eisenbach, L. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12000 · Cited by 45
“On the contrary, IL27p28 cytokine was shown to reduce inflammation by suppressing differentiation of Th17 and enhancing the development of IL10 producing anti-inflammatory T cells.(33) The anti-inflammatory cytokine IL10 is essential for maintaining intestinal homeostasis and tolerance toward commensal flora.”
BackgroundInfluentialPsoriasis and uveitis: links and risks
Fotiadou, C., & Lazaridou, E. (2019) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s179182 · Cited by 47
Yang, X., Li, S., Zhao, Y., Li, S., Zhao, T., Tai, Y., Zhang, B., Wang, X., Wang, C., Chen, J., et al. (2019) · Cells · doi:10.3390/cells8121596 · Cited by 45
“M1 macrophages in turn aggravate inflammation by producing inflammatory factors which activate fibroblast-like synovial cell (FLS) proliferation and Th17 polarization [6].”
Zidar, A., Kristl, J., Kocbek, P., & Zupančič, Š. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1908260 · Cited by 49
The tumor immune-microenvironment in gastric cancer
Fang, F., Zhang, T., Li, Q., Chen, X., Jiang, F., & Shen, X. (2022) · Tumori Journal · doi:10.1177/03008916211070051 · Cited by 47
Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets
Li, L., Lu, J., Liu, J., Wu, J., Zhang, X., Meng, Y., Wu, X., Tai, Z., Zhu, Q., & Chen, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1340677 · Cited by 54
Ankylosing spondylitis: From pathogenesis to therapy
Wei, Y., Zhang, S., Shao, F., & Sun, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113709 · Cited by 51
Metadata
- Authors
- Miossec, P., & Kolls, J. K.
- Affiliations
- Lyon 1 Université (FR)
- University of Pittsburgh (US)
- Corresponding author
- Miossec, Pierre
- Kolls, Jay K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-10
- Volume
- 11
- Issue
- 10
- Pages
- 763-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2022917731
- Cited by
- 1,414
- References
- 169
- Citations by year
- 2026: 74 · 2025: 104 · 2024: 137 · 2023: 101 · 2022: 121 · 2021: 129 · 2020: 97 · 2019: 91 · 2018: 67 · 2017: 114 · 2016: 100 · 2015: 109 · 2014: 97 · 2013: 72 · 2012: 1
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- Institut Mérieux
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, IL-17 inhibitors, IL-23, IL-17 receptor A, psoriasis, rheumatoid arthritis, ankylosing spondylitis, chronic inflammation, autoimmunity, biologic therapy, IL-17A
- MeSH terms
- Animals, Chronic Disease, Humans, Inflammation, Drug Delivery Systems, Interleukin-17, Receptors, Interleukin-17, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.